RESEARCH TRIANGLE PARK, N.C.--Embrex(R), Inc., The In Ovo Company(R),
(Nasdaq: EMBX) announced that a special meeting of its shareholders will
be held on January 19, 2007 at 9:00 a.m. local time at its corporate
headquarters at 1040 Swabia Court, Durham, North Carolina 27703 to
consider and vote upon a proposal to approve and adopt the Agreement and
Plan of Merger dated as of November 14, 2006, among Embrex, Inc., Pfizer
Inc. and Eagle Merger Sub Inc. (which is a wholly-owned subsidiary of
Pfizer) and the transactions contemplated thereby.
Only shareholders of record at the close of business on December 12,
2006, the record date, are entitled to notice of the special meeting and
to vote at such meeting.
Embrex(R), Inc., The In Ovo Company(R), is an international agricultural
biotechnology company engaged in the development of innovative in ovo
(in the egg) solutions that meet the needs of today's global poultry
industry.
Embrex(R) and The In Ovo Company(R) are trademarks of Embrex, Inc.
Additional Information and Where to Find It
This communication may be deemed to be solicitation material in respect
of the proposed acquisition of Embrex by Pfizer. In connection with the
proposed merger and related proposals that will be voted on at the
special meeting, Embrex has filed a definitive proxy statement, dated
December 12, 2006, with the U.S. Securities and Exchange Commission
("SEC"), which is being mailed on or about December 15, 2006, to
shareholders of Embrex who were shareholders as of the record date,
December 12, 2006. SHAREHOLDERS OF EMBREX ARE URGED TO READ ALL RELEVANT
DOCUMENTS FILED WITH THE SEC, INCLUDING EMBREX'S PROXY STATEMENT,
BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED
TRANSACTION. Investors and security holders can obtain the proxy
statement and other relevant documents free of charge at the SEC's web
site, http://www.sec.gov/.
Copies of such filings can also be obtained, without charge, by
directing a request to Embrex, Inc., at 1040 Swabia Court, Durham, North
Carolina 27703.
Embrex and its directors, executive officers, certain members of
management and employees may be deemed to be participants in the
solicitation of proxies of Embrex shareholders to approve the proposed
merger. Such individuals have interests in the merger, including as a
result of holding shares or options to purchase shares of Embrex stock.
Certain information regarding the participants and their interest in the
solicitation is set forth in the proxy statement for the special
shareholder meeting filed with the SEC on December 12, 2006.
Web site: http://www.embrex.com
(EMBX)
Don Seaquist of Embrex, Inc.,
+1-919-941-5185